These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 23443308)
21. Drug rechallenge and treatment beyond progression--implications for drug resistance. Kuczynski EA; Sargent DJ; Grothey A; Kerbel RS Nat Rev Clin Oncol; 2013 Oct; 10(10):571-87. PubMed ID: 23999218 [TBL] [Abstract][Full Text] [Related]
22. New targets for cancer chemotherapy. Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208 [No Abstract] [Full Text] [Related]
23. Developing drugs that do not cause tumor regression. Stadler W Clin Adv Hematol Oncol; 2003 Nov; 1(11):654-5. PubMed ID: 16258462 [No Abstract] [Full Text] [Related]
24. Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting. Corti A; Franzini M; Paolicchi A; Pompella A Anticancer Res; 2010 Apr; 30(4):1169-81. PubMed ID: 20530424 [TBL] [Abstract][Full Text] [Related]
33. Preface: National Cancer Act. Smalley KS Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037 [No Abstract] [Full Text] [Related]
34. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy. Boldrini JL; Costa MI IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031 [TBL] [Abstract][Full Text] [Related]
35. Experimental and clinical effects of anticoagulants on cancer progression. Van Noorden CJ; van Sluis GL; Spek CA Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011 [No Abstract] [Full Text] [Related]
36. Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer. Bewick MA; Conlon MS; Lafrenie RM Breast Cancer Res Treat; 2009 Oct; 117(3):667-9. PubMed ID: 19127428 [No Abstract] [Full Text] [Related]
37. Resisting resistance. Ewan S Drug Discov Today; 2005 Aug; 10(15):1015. PubMed ID: 16055015 [No Abstract] [Full Text] [Related]
39. In vitro drug resistance versus chemosensitivity: two sides of different coins. Fruehauf JP; Alberts DS J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686 [No Abstract] [Full Text] [Related]
40. [Multicenter clinical trial of the antitumor drug Dioxadet (phase II)]. Gershanovich ML; Filov VA; Kotova DG; Stukov AN; Sokolov IuN; Ivin BA Vopr Onkol; 1998; 44(2):216-20. PubMed ID: 9615831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]